Tag

Dr. Vikas Gupta

2 articles

Evonile Pharma Q2 Revenue ₹56.1 Cr, EBITDA -₹31.8 Cr

Evonile Pharma announces unaudited Q2 FY27 results with ₹56.1 crore revenue and negative ₹31.8 crore EBITDA due to transition costs. Company completed transition to independent business model after Ch

Evonile Pharma Q2 Net Loss of ₹77.5 Crore

Evonile Pharma reported a Q2 FY27 net loss of ₹77.5 crore, driven by a ₹68.3 crore exceptional item from terminating a customer agreement and ₹15.4 crore in one-time transition expenses. Revenue decli